Device Trial Radar · NCT07523620
Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Mar 31, 2026
Primary completion
May 31, 2027
Study completion Feb 28, 2028
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Apr 13, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this clinical investigation is to evaluate the feasibility, safety, and effectiveness of a concomitant procedure involving the Volt PFA System and Amulet 2 device in patients indicated for both AF ablation and percutaneous LAAO.
Conditions
- Atrial Fibrillation (AF)
- Paroxysmal AF
- Persistent Atrial Fibrillation
Interventions
PVI AblationProcedure
PVI Ablation with Pulsed Field Ablation
Left Atrial Appendage Occluder ImplantDevice
Left atrial appendage occluder implant
Primary outcomes
What the sponsor says the trial is designed to measure.
- LAA occlusion success determined by peri-device flow ≤5mmTime frame: From treatment through 3-month follow-up vists
- Occurrence of specific adverse events between time of implant and 7 days post-procedure or hospital discharge, whichever was laterTime frame: From implant of LAAO through ≤7 days post-procedure or hospital discharge, whichever is later
Locations
16 sites in 10 countries. Site status is shown where the registry gives one.
UZ Brussel
Brussels, B CAP R, Belgium · Recruiting
Motol and Homolka University Hospital
Prague, Czech Republic, Czechia · Recruiting
Rigshospitalet
Copenhagen, Copenha, Denmark · Recruiting
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.